Nanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: current progress and upcoming challenges

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorDi Filippo, Leonardo Delello-
Autor(es): dc.creatorde Paula, Mariana Carlomagno-
Autor(es): dc.creatorDuarte, Jonatas Lobato-
Autor(es): dc.creatorde Paula, Geanne Aparecida-
Autor(es): dc.creatorFrigieri, Isadora-
Autor(es): dc.creatorChorilli, Marlus-
Data de aceite: dc.date.accessioned2025-08-21T16:04:13Z-
Data de disponibilização: dc.date.available2025-08-21T16:04:13Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2022-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1080/17425247.2023.2221026-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/300430-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/300430-
Descrição: dc.descriptionIntroduction: Skin cancer is the most common form of cancer worldwide, with increasing incidence rates in recent years. Although conventional chemotherapy and radiation therapy have been used for its treatment, these therapies have several limitations such as lack of selectivity and significant side effects. Targeted nanocarriers have emerged as a promising approach for the treatment of skin cancer. Areas covered: This review article provides an overview of targeted nanocarriers for skin cancer treatment. It covers the various types of targeted nanocarriers, including liposomes, polymeric nanoparticles, dendrimers, and inorganic nanoparticles. Expert opinion: There are still several challenges that need to be addressed before the clinical translation of targeted nanoparticles, such as optimization of their properties, development of reliable and robust characterization methods, and evaluation of their safety and efficacy in clinical trials. Another key aspect for the advancement of these studies is the need to improve regulatory aspects related to the toxicity and regulation of nanomedicines targeting skin cancer. Overall, targeted nanocarriers hold great potential for the development of safe and effective treatments for skin cancer, which can contribute to a better prognosis and overall patients’ life quality.-
Descrição: dc.descriptionDepartment of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP), São Paulo-
Descrição: dc.descriptionDepartment of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP), São Paulo-
Formato: dc.format831-849-
Idioma: dc.languageen-
Relação: dc.relationExpert Opinion on Drug Delivery-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectcontrolled release-
Palavras-chave: dc.subjectmelanoma-
Palavras-chave: dc.subjectNanoparticles-
Palavras-chave: dc.subjectsurface modification-
Palavras-chave: dc.subjecttarget delivery-
Título: dc.titleNanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: current progress and upcoming challenges-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.